|
IMAGING
Contrast
enhances color Doppler endorectal sonography of prostate: efficiency for
detecting peripheral zone tumors and role for biopsy procedure
Roy C, Buy X, Lang H, Saussine C, Jacqmin D
Department of Radiology B, University Hospital of Strasbourg-Hopital Civil,
1 place de l’Hopital, 67091 Strasbourg Cedex, France
J.Urol. 2003; 170: 69-72
- Purpose:
We evaluated the accuracy of contrast enhanced color Doppler endorectal
ultrasound to guide biopsy for the detection of prostate cancer.
- Materials
and Methods: A total of 85 patients were evaluated with gray
scale and color Doppler before and during intravenous injection of ultrasound
contrast agent made of galactose based air micro bubbles. Our biopsy
protocol was performed during contrast injection. An additional 18 directed
cores were obtained based on contrast-enhanced imaging. Diagnostic efficiency
with and without contrast medium injection for detecting prostate cancer
was compared based on biopsy results.
-
Results:
Cancer was identified in a total of 58 biopsy sites in 54 patients.
Gray scale imaging revealed 96 abnormal hypoechoic nodules or irregular
zones inside the outer gland, of which 48 were malignant on pathological
evaluation. Contrast enhanced color Doppler had higher sensitivity (93%)
than unenhanced color Doppler (54%), while specificity increased only
79% to 87% for enhanced imaging. Nine of 10 isoechoic suspicious zones
were depicted with enhancement, while unenhanced Doppler detected 7
of them. There was no significant difference between the intensity of
enhancement and tumor Gleason scores.
- Conclusions:
Contrast enhanced color Doppler endorectal sonography increases the
detection of prostate cancer. Improvement in sensitivity was high, while
the difference in specificity was not as pertinent. It is accurate when
using a common and routine application ultrasound unit. This technique
is easy to perform and not time-consuming. Obtaining additional biopsy
cores of suspicious enhancing foci significantly improves the detection
rate of cancer.
- Editorial
Comment
Color Doppler ultrasound (CDUS) has already been proved to be of a great
value as a complementary method for the detection of prostate cancer
during transrectal guided biopsy. Although it has proven utility, unfortunately,
this method is not used routinely in many centers. Some of the reasons
may be explained by the fact that CDUS of the prostate requires high
resolution modern equipments (with power Doppler), dedicated and experienced
sonographer and appropriate control settings. The use of energy Doppler
(Doppler angiography, power Doppler) is better than velocity Doppler
in order to demonstrate subtle area of abnormal flow (areas with increased
neovascularity). This occurs because energy Doppler is not dependent
of the angle of the ultrasound beam. The use of microbubbles as an echo-contrast
improves the ability of CDUS to better demonstrate the neovascularity
associated with cancer. We have found that this phenomenon is particularly
useful in large prostate gland (> 60 grams), prostate gland with
isoechoic peripheral zone and prostate gland showing 2, 3 or more suspicious
areas. Obviously 2 or 3 cores of the area with abnormal flow must be
taken additionally to the cores obtained by the systematic biopsy. In
our department routinely used CDUS without and with echo-contrast demonstrated
respectively, 8% and 15% of cancer not seen on gray-scale US examination
(isoechoic cancer) (1). The authors present a high sensitivity and specificity
of the contrast enhanced CDUS (93 and 87% respectively). Other studies
has been shown that Doppler angio-sonography (power Doppler) with eco-contrast
increased the detection of prostate cancer from 38 % to 85% with an
80% specificity (2). There is no doubt that power Doppler ultrasound,
preferably with eco-contrast should be used routinely during transrectal
biopsy of the prostate. This technique is particularly helpful in normal
appearance prostate gland (mainly those larger than 60 grams), prostate
with more than one suspicious area and in patients with negative biopsies
and rising PSA.
References
1. Prando A: The value of color in detection of prostate cancer. Radiol
Brasil. 1998; 30: 233-7. [in Portuguese]
2. Bogers HA, Sedelaar JP,Beelarge HP et al.: Contrast-enhanced 3-D power
Doppler of the prostate: correlation with biopsy outcome. Urology 1999;
54: 97-104.
Dr.
Adilson Prando
Department of Radiology
Vera Cruz Hospital
Campinas, São Paulo, Brazil
|